Unique Ingredient Identifier 33X04XA5AT is listed as a unspecified ingredient
| NCIT | C76926 |
| RXCUI | 28393 |
UNII 33X04XA5AT LACTIC ACID, UNSPECIFIED FORM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | 0.12 % |
| AURICULAR (OTIC) | SOLUTION, DROPS | ADJPH |
| IM - IV | INJECTION | 100 % |
| IM - IV - SC | INJECTION | 0.012 % |
| IM - IV - SC | SOLUTION, INJECTION | NA |
| INTRACARDIAC | INJECTION | 0.012 % |
| INTRACARDIAC | SOLUTION, INJECTION | NA |
| INTRAMUSCULAR | INJECTABLE | NA |
| INTRAMUSCULAR | INJECTION | ADJPH |
| INTRAVENOUS | INJECTABLE | 0.41 % |
| INTRAVENOUS | INJECTION | 0.9 MG/1ML |
| INTRAVENOUS | INJECTION | 0.71 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.1 % |
| IV(INFUSION) | INJECTION | 1.86 % |
| IV(INFUSION) | SOLUTION, INJECTION | 0.13 % |
| NERVE BLOCK | INJECTION | 0.12 % |
| ORAL | CAPSULE | 1.6 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 44 MG |
| ORAL | CONCENTRATE | 0.18 %W/W |
| ORAL | SOLUTION | ADJPH |
| ORAL | SYRUP | NA |
| ORAL | TABLET | ADJPH |
| PARENTERAL | INJECTION | NA |
| SUBCUTANEOUS | INJECTION | 0.34 % |
| TOPICAL | AEROSOL | 1.05 %W/W |
| TOPICAL | AEROSOL, FOAM | 1 %W/W |
| TOPICAL | CREAM | 0.05 %W/W |
| TOPICAL | CREAM | ADJ PH |
| TOPICAL | EMULSION, AEROSOL FOAM | 1.05 %W/W |
| TOPICAL | EMULSION, CREAM | 1 %W/W |
| TOPICAL | GEL | 6.07 %W/W |
| TOPICAL | LOTION | 5.7 %W/W |
| TOPICAL | OINTMENT | NA |
| TOPICAL | SOLUTION | 7.22 %W/W |
| TOPICAL | SUSPENSION | 0.7 %W/W |
| VAGINAL | EMULSION, CREAM | 0.81 % |
| VAGINAL | SUPPOSITORY | NA |
| VAGINAL | TABLET | 70 MG |